01—Abstract
Summary
Summary of the 10-K filed February 28, 2019. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported strong performance in its 2018 fiscal year, characterized by robust revenue growth and an increase in average daily trading volumes across key asset classes.
The acquisition of NEX Group plc in November 2018 was a significant event, expanding CME's reach into cash and OTC markets and diversifying its product and service offerings, particularly in fixed income and foreign exchange. Financially, the company demonstrated resilience, with total revenues growing to $4.31 billiona. Despite increased operating expenses related to the NEX integration and other strategic initiatives, CME Group maintained healthy operating margins.
The company's strategic focus on maximizing futures and options growth, diversifying its business, and delivering capital efficiency appears to be driving positive results. Investors will likely find the company's continued investment in technology and global expansion reassuring, though the competitive and regulatory landscapes remain key areas to monitor.
02—Key points
Key Highlights
- Total revenues increased by 18% to $4.31 billion in 2018, driven by strong clearing and transaction fees and market data services.
- Average daily volume across all product lines saw an 18% increase, reaching 19.2 million contracts, with significant growth in interest rate and equity index products.
- The acquisition of NEX Group plc in November 2018 expanded CME Group's capabilities into cash and OTC markets, notably in fixed income (BrokerTec) and FX (EBS).
- The company continues to focus on growth initiatives, including cross-asset sales, international expansion, and new product development, such as SOFR and SONIA futures.
- Operating expenses increased by 28% primarily due to the integration of NEX, transaction costs, and foreign currency fluctuations.
- Despite increased expenses, CME Group maintained a strong operating margin of 61%, reflecting the underlying health and efficiency of its core business.
- The company's financial position remained solid, with cash flow from operations of $2.44 billion and a strong credit rating.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2018filed February 28, 2019Financial Statements
FY2018 against FY2017
| Line item | FY2018FY2017 | Change |
|---|---|---|
| Revenue | $4.31B$3.64B | +18.2% |
| Operating Expenses | $1.70B$1.33B | +27.6% |
| Operating Income | $2.61B$2.31B | +12.9% |
| Net Income | $1.96B$4.06B | −51.7% |
| EPS (Basic) | $5.73$12.00 | −52.2% |
| EPS (Diluted) | $5.71$11.94 | −52.2% |
| Shares Outstanding (Basic) | 342.34M338.71M | +1.1% |
| Shares Outstanding (Diluted) | 343.74M340.23M | +1.0% |
05—Questions
Frequently Asked Questions
What was the impact of the NEX Group acquisition on CME Group's financial performance in 2018?
The acquisition of NEX Group plc, completed in November 2018, significantly expanded CME Group's business by integrating NEX's cash and OTC market platforms, including BrokerTec for fixed income and EBS for FX. This contributed to an 18% increase in total revenues for the year, although it also led to higher operating expenses due to integration costs, transaction expenses, and foreign currency impacts.
How did CME Group's trading volumes perform in 2018, and which asset classes showed the most growth?
CME Group experienced an 18% increase in average daily trading volume in 2018, reaching 19.2 million contracts. The strongest growth was observed in interest rate products (up 22%) and equity index products (up 34%), driven by market volatility related to monetary policy and geopolitical factors. FX and agricultural commodities also showed solid growth.
What are CME Group's key strategic initiatives for future growth?
CME Group's strategy focuses on three main pillars: maximizing futures and options growth globally through new product launches and customer acquisition; diversifying its business and revenues by expanding into cash and OTC markets (bolstered by the NEX acquisition); and delivering unparalleled capital and cost efficiency solutions to clients. They are also actively expanding their international footprint, particularly in emerging markets.
What is CME Group's approach to managing financial and regulatory risks?
CME Group operates in a heavily regulated environment and faces significant competition. Key risks include regulatory changes (like EMIR 2.2 and MiFID II), competition from other exchanges and alternative trading venues, cybersecurity threats, and potential impacts from market volatility and economic conditions. The company actively monitors and participates in rulemaking processes and invests in robust technology and risk management systems to mitigate these risks.
06—Continue